Comparing the current results to its competitors, Becton Dickinson reported Revenue decrease in the 3 quarter 2026 year on year by -9.55 %, despite the revenue increase by the most of its competitors of 2.98 %, recorded in the same quarter.
Becton Dickinson's Comment on Competition and Industry Peers
The company faces risks of product obsolescence resulting from changes in customer preferences, industry or regulatory standards, and competitors' innovations. It is also exposed to foreign currency exchange risks impacting international revenue, influenced by political and economic factors including tariffs and inflation. Additionally, the company encounters cybersecurity risks that may cause increased costs, reputational damage, financial losses, operational disruptions, and regulatory consequences.
Publicly Traded Peers of Becton Dickinson And Company
Lemaitre Vascular Inc Share Performance
-1.07%
This Year
Lemaitre Vascular Inc
Profile
Lemaitre Vascular Inc is a medical device company specializing in the design, development, and distribution of innovative medical devices for the treatment of peripheral vascular disease. Their business model revolves around creating and manufacturing high-quality products that address specific needs in the field of vascular surgery. They leverage a combination of direct sales, distribution partnerships, and ongoing research and development efforts to effectively reach healthcare professionals and provide comprehensive solutions for patients.
Angiodynamics Inc is a medical technology company that focuses on the development and commercialization of devices and treatments for minimally invasive procedures. Their business model centers around the manufacturing and sale of innovative medical devices such as catheters, lasers, and fluid systems used in the diagnosis and treatment of various vascular conditions. They primarily generate revenue through the sale of these products to healthcare providers and hospitals worldwide.
Atricure Inc is a medical device company that focuses on developing, manufacturing, and selling innovative surgical solutions for the treatment of cardiac arrhythmias and other heart-related conditions.
Penumbra Inc operates on a business model that focuses on the development and manufacturing of innovative medical devices. They aim to provide cutting-edge technologies and solutions to improve patient outcomes in various medical fields. The company primarily generates revenue through the sales of their medical devices to healthcare professionals and institutions worldwide.
Livanova Plc is a global medical technology company that focuses on developing and delivering innovative solutions for patients with cardiovascular diseases and neuropsychiatric disorders. Through their diverse portfolio, they offer products and therapies that encompass surgical heart valves, cardiac rhythm management, and neuromodulation. Livanova adopts a patient-centric approach, collaborating with healthcare professionals to improve patient outcomes and enhance quality of life.
Sources:
Becton Dickinson And Company’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Becton Dickinson And Company versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
